Schröder K, Martoglio B, Hofmann M, Hölscher C, Hartmann E, Prehn S, Rapoport T A, Dobberstein B
Zentrum für Molekulare Biologie der Universität Heidelberg (ZMBH), Postfach 106249, 69052 Heidelberg, Germany.
EMBO J. 1999 Sep 1;18(17):4804-15. doi: 10.1093/emboj/18.17.4804.
Protein translocation across the membrane of the endoplasmic reticulum (ER) proceeds through a proteinaceous translocation machinery, the translocon. To identify components that may regulate translocation by interacting with nascent polypeptides in the translocon, we used site-specific photo-crosslinking. We found that a region C-terminal of the two N-glycosylation sites of the MHC class II-associated invariant chain (Ii) interacts specifically with the ribosome-associated membrane protein 4 (RAMP4). RAMP4 is a small, tail-anchored protein of 66 amino acid residues that is homologous to the yeast YSY6 protein. YSY6 suppresses a secretion defect of a secY mutant in Escherichia coli. The interaction of RAMP4 with Ii occurred when nascent Ii chains reached a length of 170 amino acid residues and persisted until Ii chain completion, suggesting translocational pausing. Site-directed mutagenesis revealed that the region of Ii interacting with RAMP4 contains essential hydrophobic amino acid residues. Exchange of these residues for serines led to a reduced interaction with RAMP4 and inefficient N-glycosylation. We propose that RAMP4 controls modification of Ii and possibly also of other secretory and membrane proteins containing specific RAMP4-interacting sequences. Efficient or variable glycosylation of Ii may contribute to its capacity to modulate antigen presentation by MHC class II molecules.
蛋白质跨内质网(ER)膜的转运通过一种蛋白质转运机制——易位子进行。为了鉴定可能通过与易位子中的新生多肽相互作用来调节转运的成分,我们使用了位点特异性光交联技术。我们发现,MHC II类相关恒定链(Ii)的两个N-糖基化位点的C末端区域与核糖体相关膜蛋白4(RAMP4)特异性相互作用。RAMP4是一种由66个氨基酸残基组成的小的尾锚定蛋白,与酵母YSY6蛋白同源。YSY6可抑制大肠杆菌中secY突变体的分泌缺陷。当新生的Ii链达到170个氨基酸残基的长度时,RAMP4与Ii发生相互作用,并持续到Ii链合成完成,提示转运过程中的暂停。定点诱变显示,Ii与RAMP4相互作用的区域含有必需的疏水氨基酸残基。将这些残基替换为丝氨酸会导致与RAMP4的相互作用减弱以及N-糖基化效率低下。我们提出,RAMP4控制Ii以及可能还控制其他含有特定RAMP4相互作用序列的分泌蛋白和膜蛋白的修饰。Ii的高效或可变糖基化可能有助于其调节MHC II类分子抗原呈递的能力。